Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio Elpida
Saint-Priest, Francebio-elpida.com ↗
- Ownership
- Private
- Employees
- ~45
- Development stage
- Other
01
Overview
Bio Elpida provides GMP-compliant services for the development and manufacturing of advanced cell therapies and biologic products, focused on pre-clinical and clinical phases. No clinical trial outcomes or specific late-stage clinical results publicly available; company is mainly a partner/enabler for biotech and pharma development programs.
- Therapeutic areas
- OncologyRare DiseasesImmunology
- Modalities
- Cell therapyBiologicMonoclonal antibodyVaccineProtein
- Industry
- Contract Manufacturing Organization
02
Partnerships
PolyplusExternal fill and finish partners (unnamed)
Beyond the preview
Go deeper on Bio Elpida.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio Elpida.